The «Medsintez» plant is a pharmaceutical manufacturer
The company produces infusion solutions, finished dosage forms and API of human insulin and solid and liquid medications. «Medsintez» was one of the first industrial manufacturers of finished dosage forms of genetically engineered human insulin in Russia, who met GMP EC requirements.
Production Facilities
The following production lines are successfully run at the «Medsintez» plant: liquid dosage forms, solid dosage forms, aseptic bottling of recombinant and analogue preparations, recombinant and analogue preparation's APIs by biotechnological synthesis method production, APIs by chemical synthesis method production.
OEM Manufacturing
One of the main growth directions for our business is OEM manufacturing or manufacturing products under a customer’s trademark. We partner with leading global manufacturers of pharmaceutical and medical products.
Finished Products
Since the opening of our plant, more 10 million «Rosinsulin» packages have been produced: solution, suspension and two-phase insulin in bottles, cartridges, pre-filled syringe pens. Drugs are purchased in all regions of the Russian Federation and abroad.
News
-
The Medsintez Plant, together with the Ural State Medical University (USMU), continues to work on the manufacture of new drugs on the basis of a full-cycle scientific and educational complex
01 / 02 / 2023On January 31, 2023, a TASS press conference was held dedicated to the joint scientific and...
The Medsintez Plant took part in the Scientific and Practical Conference of Pediatric Endocrinologists of the Sverdlovsk Region
06 / 12 / 2022On November 26, 2022, the Medsintez Plant took part in the Scientific and Practical Conference of...
Videos
Pharmacovigilance
«Medsintez» is committed to safety of its products and health of its patients.
Following both ethical principles and requirements of Russian legislation, the company collects and analyses data related to side effects and drug interactions and closely works with regulators in this area. To monitor the effectiveness and safety of their drugs, the company introduced Good EAF Pharmacovigilance Practice.
If you want to report an adverse reaction occurring during the use of a «Medsintez» drug, please contact your doctor.
Also, you can:
Report an adverse reaction via:
• Fill out the attached form on the site www.drugsafety.ru
• Send information by e-mail: adversereaction@drugsafety.ru
• Сall the free round-the-clock phone: 8-800-777-8-604
• Send massage via WhatsApp, Viber: +7-903-799-2-186
Quality
The plant has the МС ISO 9001:2015 quality control system in place. The Quality Director's service structure, which includes the quality control and assurance departments, is in full compliance with GMP standards. The core staff was trained at Bayer AG in Leverkusen and Berlin. All plant employees were trained in GMP requirements at special training organizations or at the enterprise itself.
The «Medsintez» plant was founded in 2003. Today, it is part of the «Ural Biomedical Cluster» Non-Profit Partnership, which comprises more than 30 member companies and is also a member of the Association of Medical and Pharmaceutical Manufacturers of the Sverdlovsk Region.
Customer health care is our priority! With any wishes, suggestions, questions or complaints regarding the quality of Medsintez plant products, feel free to contact us by phone
8-800-200-8434 (6:00 to 17:00 Moscow time) or by filling out the electronic form here
Torgovaya 15, Novouralsk, Sverdlovsk region, Russia, 624130